Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

by | Nov 22, 2026 | Health

Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

A Royal College of Physicians investigation into brain tumor treatment practices at University Hospitals Coventry and Warwickshire NHS trust identified significant failures in patient care spanning multiple years. The inquiry was initiated following concerns raised by colleagues after the retirement of clinical oncologist Prof Ian Brown, whose patients were subsequently transferred to other care providers.

The report examined 20 patient cases, determining that 15 had received unsatisfactory care while five required improvement. Investigators found that multiple patients were maintained on extended cycles of the chemotherapy drug temozolomide far exceeding standard treatment protocols, often without clinical evidence supporting continued administration. Several patients continued receiving chemotherapy despite disease progression, when palliative care approaches would have been more appropriate.

Notable cases included one patient who received more than a decade of chemotherapy while misdiagnosed with a high-grade glioblastoma, later found to actually have a low-grade pilocytic astrocytoma requiring no chemotherapy. Another patient endured 10 years of treatment accompanied by severe adverse effects including persistent fatigue, nausea, and shingles requiring hospitalization. One patient received over 100 chemotherapy cycles across a 10-year period after being incorrectly diagnosed with grade-4 glioblastoma and given a prognosis of six to 12 months to live. Multiple patients reported being told that ceasing chemotherapy would result in death.

Trust leadership issued apologies for the clinical and governance failures. The organization stated it would ensure independent case review for all living patients who received more than 12 cycles of temozolomide. A legal firm representing over 40 patients has called for an independent public inquiry into the matter.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI